Vitamin K2 and CVD risk markers.

• Conditions: cardio vascular disease, CVD, atherosclerosis

• Registration Number: NL-OMON24375
• Lead Sponsor: ?

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

1. Men and women age 40-65 years;

2. Postmenopausal assed by self-report;

Exclusion Criteria

1. Using vitamin K antagonists;

2. Using chronic medication for cardiovascular diseases
for women;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
MGP levels in blood.

Secondary Outcome Measures

Name	Time	Method
1. Blood lipid profile;<br /><br>2. Inflammation markers;<br /><br>3. Insulin sensitivity;<br /><br>4. Adipokines;<br /><br>5. Osteocalcin carboxlation.